Nwaru,Bright I.et al"Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme."European Respiratory Journal(2020):1901872.Web. 17 April. 2021.